Your browser doesn't support javascript.
loading
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.
Oaknin, Ana; Gilbert, Lucy; Tinker, Anna V; Brown, Jubilee; Mathews, Cara; Press, Joshua; Sabatier, Renaud; O'Malley, David M; Samouelian, Vanessa; Boni, Valentina; Duska, Linda; Ghamande, Sharad; Ghatage, Prafull; Kristeleit, Rebecca; Leath, Charles III; Guo, Wei; Im, Ellie; Zildjian, Sybil; Han, Xinwei; Duan, Tao; Veneris, Jennifer; Pothuri, Bhavana.
Affiliation
  • Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain aoaknin@vhio.net.
  • Gilbert L; Department of Gynecologic Oncology, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.
  • Tinker AV; Department of Medicine, BC Cancer, Vancouver, British Columbia, Canada.
  • Brown J; Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Mathews C; Department of Gynecological Oncology, Women and Infants Hospital of Rhode Island, Providence, Rhode Island, USA.
  • Press J; Gynecologic Oncology and Pelvic Surgery, Swedish Cancer Institute, Seattle, Washington State, USA.
  • Sabatier R; Department of Medical Oncology, Institut Paoli Calmettes, Aix-Marseille University, Marseille, France.
  • O'Malley DM; Department of Obstetrics and Gynecology, The Ohio State University James Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Samouelian V; Gynecologic Oncology Service, Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Québec, Canada.
  • Boni V; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • Duska L; Department of Gynecological Oncology, Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA.
  • Ghamande S; Georgia Cancer Center, Augusta University, Augusta, Georgia, USA.
  • Ghatage P; Department of Gynecological Oncology, University of Calgary, Calgary, Alberta, Canada.
  • Kristeleit R; Department of Oncology, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.
  • Leath C III; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Guo W; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Im E; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Zildjian S; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Han X; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Duan T; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Veneris J; GlaxoSmithKline, Waltham, Massachusetts, USA.
  • Pothuri B; Department of Obstetrics and Gynecology, NYU Langone Health, Perlmutter Cancer Center, New York University, New York, New York, USA.
J Immunother Cancer ; 10(1)2022 01.
Article de En | MEDLINE | ID: mdl-35064011
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Marqueurs biologiques tumoraux / Tumeurs de l'endomètre / Instabilité des microsatellites / Réparation de mésappariement de l'ADN / Anticorps monoclonaux humanisés Limites: Female / Humans / Middle aged Langue: En Journal: J Immunother Cancer Année: 2022 Type de document: Article Pays d'affiliation: Espagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Marqueurs biologiques tumoraux / Tumeurs de l'endomètre / Instabilité des microsatellites / Réparation de mésappariement de l'ADN / Anticorps monoclonaux humanisés Limites: Female / Humans / Middle aged Langue: En Journal: J Immunother Cancer Année: 2022 Type de document: Article Pays d'affiliation: Espagne